Morales David L S, Lorts Angela, Rizwan Raheel, Zafar Farhan, Arabia Francisco A, Villa Chet R
From the *The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; and †Cedars-Sinai Heart Institute, Los Angeles, California.
ASAIO J. 2017 Jul/Aug;63(4):518-519. doi: 10.1097/MAT.0000000000000504.
Individual centers have documented the use of the Syncardia Total Artificial Heart (TAH) in adolescents with heart failure; however, the number of patients at any given center is small. Herein, we describe the worldwide experience for all patients ≤21 years old supported with the TAH between May 2005 and May 2015 (n = 43). The number of patients experiencing a positive outcome at 60, 90, and 120 days were 30 (70%), 27 (63%), and 25 (58%), respectively. Successful bridge to transplantation varied by diagnosis, but outcomes reported are similar to adults supported with the TAH or biventricular assist devices.
各个中心都记录了在青少年心力衰竭患者中使用Syncardia全人工心脏（TAH）的情况；然而，在任何一个特定中心的患者数量都很少。在此，我们描述了2005年5月至2015年5月期间接受TAH支持的所有≤21岁患者的全球经验（n = 43）。在60天、90天和120天时出现阳性结果的患者数量分别为30例（70%）、27例（63%）和25例（58%）。成功过渡到移植的情况因诊断而异，但报告的结果与接受TAH或双心室辅助装置支持的成人相似。
